CAR-T Meeting 2023 | The promise of CAR-T therapy in adult ALL and future outlooks
Mohamad Mohty
• 10 Feb 2023
Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, shares some insights into the value of CAR-T therapy and other immunotherapeutic agents in the treatment of acute lymphoblastic leukemia (ALL). Prof. Mohty highlights the growing use of CAR-T therapy in adult patients, and also comments on the need to address the question of whether allogeneic stem cell transplantation (alloSCT) is required as consolidation therapy after treatment with CAR-T cells. This interview took place at the EBMT-EHA 5th European CAR T-cell Meeting held in Rotterdam, The Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
